Govt to discuss TMR with pharma bodies on May 16

The federal government is about to revive talks on the contentious problem of commerce margin rationalisation (TMR) on medicine and medical gadgets with trade stakeholders at a gathering on Might 16.

On this regard, the Division of Prescribed drugs (DoP) and the Nationwide Pharmaceutical Pricing Authority (NPPA) have invited members of pharma associations and medical gadget producers for the assembly and sought their strategies by Friday.

“The DoP and NPPA have been receiving varied strategies from the trade for amendments in DPCO, 2013 and Nationwide Pharmaceutical Pricing Coverage. Therefore, it has been determined to organise a workshop with trade stakeholders with the participation of the associations of pharma and the medical gadget sector,” mentioned the invite. The members of the foyer teams are anticipated to open up the dialogue of introducing TMR on pharmaceutical formulations. A number of small and medium pharma firms had additionally instructed that the federal government ought to undertake the ‘one-molecule, one-price’ formulation.